{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:36:42Z","timestamp":1791599802414,"version":"4.3.4"},"reference-count":82,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG066530"],"award-info":[{"award-number":["P30 AG066530"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG016573"],"award-info":[{"award-number":["AG016573"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG079307"],"award-info":[{"award-number":["RF1 AG079307"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG061794"],"award-info":[{"award-number":["RF1 AG061794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG072291"],"award-info":[{"award-number":["R01 AG072291"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032774","name":"Remondi Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020392","name":"Good Ventures Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.celrep.2024.114982","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T22:50:27Z","timestamp":1732747827000},"page":"114982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"43","author":[{"given":"Guoqiang George","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Mazzarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Andrea","family":"Perez-Corredor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayk","family":"Davtyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Blurton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Arboleda-Velasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3938-5839","authenticated-orcid":false,"given":"Yanhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.114982_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.molmed.2022.05.008","article-title":"Staging of Alzheimer's disease: past, present, and future perspectives","volume":"28","author":"Therriault","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870517","article-title":"Impact of Anti-amyloid-beta Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab","volume":"14","author":"Shi","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.celrep.2024.114982_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2019.07.010","article-title":"A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP \u03b2-CTFs, Not A\u03b2","volume":"104","author":"Kwart","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2024.114982_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1292-335","article-title":"Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3","volume":"2","author":"Van Broeckhoven","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2024.114982_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng1292-330","article-title":"Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14","volume":"2","author":"St George-Hyslop","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2024.114982_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114982_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114982_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ng1095-219","article-title":"The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families","volume":"11","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2024.114982_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in\u00a0vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114982_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114982_bib14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","article-title":"Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42\/1-40 ratio in\u00a0vitro and in\u00a0vivo","volume":"17","author":"Borchelt","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2024.114982_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2024.114982_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114982_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2024.114982_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI113096","article-title":"Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia","volume":"80","author":"Wardell","year":"1987","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2024.114982_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-9-11","article-title":"ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer\u2019s disease","volume":"9","author":"Medway","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2024.114982_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","article-title":"Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease","volume":"79","author":"Le Guen","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2024.114982_bib21","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2024.114982_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.conb.2015.11.003","article-title":"Modeling psychiatric disorders with patient-derived iPSCs","volume":"36","author":"Wen","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.celrep.2024.114982_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00441-017-2713-x","article-title":"Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases","volume":"371","author":"Li","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.celrep.2024.114982_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13238-019-0638-8","article-title":"Modeling neuropsychiatric disorders using human induced pluripotent stem cells","volume":"11","author":"Wang","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1198715","article-title":"Modeling brain macrophage biology and neurodegenerative diseases using human iPSC-derived neuroimmune organoids","volume":"17","author":"Cerneckis","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.celrep.2024.114982_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.molmed.2023.05.007","article-title":"Pushing the boundaries of brain organoids to study Alzheimer's disease","volume":"29","author":"Cerneckis","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101462","article-title":"Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum\u00a0Exposure","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2024.114982_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112841","article-title":"Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114982_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2024.114982_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","article-title":"iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases","volume":"94","author":"Abud","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2024.114982_bib35","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","article-title":"APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114982_bib36","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.stemcr.2023.05.018","article-title":"Familial Alzheimer's disease-associated PSEN1 mutations affect neurodevelopment through increased Notch signaling","volume":"18","author":"Hurley","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.celrep.2024.114982_bib37","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","article-title":"Modeling amyloid beta and tau pathology in human cerebral organoids","volume":"23","author":"Gonzalez","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.celrep.2024.114982_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1373568","article-title":"APOE3 Christchurch modulates \u03b2-catenin\/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer's cases","volume":"17","author":"Perez-Corredor","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.celrep.2024.114982_bib39","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.114982_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13024-018-0297-x","article-title":"Development and validation of a simplified method to generate human microglia from pluripotent stem cells","volume":"13","author":"McQuade","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2024.114982_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.stem.2020.12.018","article-title":"ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/brain\/awn109","article-title":"Debris clearance by microglia: an essential link between degeneration and regeneration","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2024.114982_bib44","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.tins.2020.10.002","article-title":"Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics","volume":"43","author":"Podle\u015bny-Drabiniok","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.celrep.2024.114982_bib45","doi-asserted-by":"crossref","first-page":"37246","DOI":"10.1074\/jbc.M604427200","article-title":"Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes","volume":"281","author":"Li","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2024.114982_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108648","article-title":"Effects of overexpression of ACSL1 gene on the synthesis of unsaturated fatty acids in adipocytes of bovine","volume":"695","author":"Zhao","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.celrep.2024.114982_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and Transferrin Regulate Ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2024.114982_bib49","doi-asserted-by":"crossref","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","article-title":"Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses","volume":"113","author":"Ou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114982_bib50","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.4049\/jimmunol.146.9.3110","article-title":"Annexin III translocates to the periphagosomal region when neutrophils ingest opsonized yeast","volume":"146","author":"Ernst","year":"1991","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.114982_bib51","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/eji.201847801","article-title":"Soluble CD93 is an apoptotic cell opsonin recognized by alpha(x) beta(2)","volume":"49","author":"Blackburn","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2024.114982_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1189\/jlb.71.1.133","article-title":"Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning","volume":"71","author":"Steinberger","year":"2002","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.celrep.2024.114982_bib53","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1189\/jlb.71.5.890","article-title":"Regulation of NRAMP1 gene expression by 1alpha,25-dihydroxy-vitamin D(3) in HL-60 phagocytes","volume":"71","author":"Roig","year":"2002","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.celrep.2024.114982_bib54","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm1096-1146","article-title":"The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology","volume":"2","author":"Lemere","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/10715762.2021.1898603","article-title":"Lipid composition dictates the rate of lipid peroxidation in artificial lipid droplets","volume":"55","author":"Lange","year":"2021","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.celrep.2024.114982_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1104725","article-title":"Lipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death","volume":"11","author":"Danielli","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.celrep.2024.114982_bib57","doi-asserted-by":"crossref","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","article-title":"Biochemistry and cell biology of tau protein in neurofibrillary degeneration","volume":"2","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib58","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer's disease","volume":"26","author":"Lasagna-Reeves","year":"2012","journal-title":"Faseb. J."},{"key":"10.1016\/j.celrep.2024.114982_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40120-017-0070-z","article-title":"The Study of Postmortem Human Synaptosomes for Understanding Alzheimer's Disease and Other Neurological Disorders: A Review","volume":"6","author":"Jhou","year":"2017","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.celrep.2024.114982_bib60","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s42003-022-04268-x","article-title":"Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer\u2019s disease","volume":"5","author":"Algamal","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.celrep.2024.114982_bib61","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41467-022-28551-x","article-title":"Disruption of the grid cell network in a mouse model of early Alzheimer\u2019s disease","volume":"13","author":"Ying","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114982_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/exnr.2001.7541","article-title":"Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides","volume":"167","author":"Laskowitz","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.celrep.2024.114982_bib63","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.stem.2023.05.013","article-title":"Context matters: hPSC-derived microglia thrive in a humanized brain environment in\u00a0vivo","volume":"30","author":"Cerneckis","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.celrep.2024.114982_bib65","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.tins.2020.10.002","article-title":"Microglial phagocytosis: a disease-associated process emerging from Alzheimer\u2019s disease genetics","volume":"43","author":"Podle\u015bny-Drabiniok","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.celrep.2024.114982_bib66","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jnr.24419","article-title":"Microglial phagocytosis in aging and Alzheimer's disease","volume":"98","author":"Gaband\u00e9-Rodr\u00edguez","year":"2020","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.celrep.2024.114982_bib67","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1016\/j.febslet.2006.07.078","article-title":"Extracellular tau is toxic to neuronal cells","volume":"580","author":"G\u00f3mez-Ramos","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.celrep.2024.114982_bib68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2478\/s13380-012-0032-y","article-title":"Soluble forms of tau are toxic in Alzheimer's disease","volume":"3","author":"Kopeikina","year":"2012","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.celrep.2024.114982_bib69","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","article-title":"Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease","volume":"28","author":"Bao","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2024.114982_bib70","article-title":"Amyloid \u03b2 Induces Lipid Droplet-Mediated Microglial Dysfunction in Alzheimer\u2019s Disease","author":"Prakash","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.114982_bib71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2024.114982_bib72","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","article-title":"Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity","volume":"29","author":"Victor","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib73","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer's disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114982_bib74","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","article-title":"The APOE-R136S mutation protects against APOE4-driven Tao pathology, neurodegeneration and neuroinflammation","volume":"26","author":"Nelson","year":"2023","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.celrep.2024.114982_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2023.11.029","article-title":"APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and spread","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib76","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.stem.2018.07.009","article-title":"GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2024.114982_bib77","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2024.114982_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.776879","article-title":"The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis","volume":"12","author":"Fuentelsaz-Romero","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.114982_bib79","article-title":"Modeling Human Cytomegalovirus-Induced Microcephaly in Human iPSC-Derived Brain Organoids","volume":"1","author":"Sun","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2024.114982_bib80","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","article-title":"Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles","volume":"286","author":"Guo","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2024.114982_bib81","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.febslet.2013.01.051","article-title":"Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau","volume":"587","author":"Guo","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.celrep.2024.114982_bib82","doi-asserted-by":"crossref","first-page":"19440","DOI":"10.1074\/jbc.M112.346072","article-title":"Trans-cellular propagation of Tau aggregation by fibrillar species","volume":"287","author":"Kfoury","year":"2012","journal-title":"J.\u00a0Biol. Chem."}],"updated-by":[{"DOI":"10.1016\/j.celrep.2026.117853","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000}}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724013330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724013330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T19:49:00Z","timestamp":1786304940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724013330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2211124724013330"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114982","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114982"}}